TrialFrontiers in cellular and infection microbiology2026
Vonoprazan-based dual therapy with amoxicillin or doxycycline versus bismuth-containing quadruple therapy for
Haocheng Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.